S&P 500   3,640.47
DOW   29,225.61
QQQ   271.87
Yes, You Can Negotiate with Franchisors. Here's How.
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
A Trio of Q3 Winners With Room to Run
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
2 Casino Stocks Worth Taking a Look At
Asian stocks follow Wall St. higher after UK calms markets
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Small-Cap Healthcare Name Is Outperforming Its Index
What Cintas Can Teach Investors About This Bear Market?
S&P 500   3,640.47
DOW   29,225.61
QQQ   271.87
Yes, You Can Negotiate with Franchisors. Here's How.
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
A Trio of Q3 Winners With Room to Run
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
2 Casino Stocks Worth Taking a Look At
Asian stocks follow Wall St. higher after UK calms markets
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Small-Cap Healthcare Name Is Outperforming Its Index
What Cintas Can Teach Investors About This Bear Market?
S&P 500   3,640.47
DOW   29,225.61
QQQ   271.87
Yes, You Can Negotiate with Franchisors. Here's How.
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
A Trio of Q3 Winners With Room to Run
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
2 Casino Stocks Worth Taking a Look At
Asian stocks follow Wall St. higher after UK calms markets
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Small-Cap Healthcare Name Is Outperforming Its Index
What Cintas Can Teach Investors About This Bear Market?
S&P 500   3,640.47
DOW   29,225.61
QQQ   271.87
Yes, You Can Negotiate with Franchisors. Here's How.
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
A Trio of Q3 Winners With Room to Run
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
2 Casino Stocks Worth Taking a Look At
Asian stocks follow Wall St. higher after UK calms markets
Biden: By 2030, 50% Of All Vehicles Will Be Electric. Sparking New "Lithium Gold Rush." (Ad)
This Small-Cap Healthcare Name Is Outperforming Its Index
What Cintas Can Teach Investors About This Bear Market?
OTCMKTS:CURLF

Curaleaf - CURLF Stock Forecast, Price & News

$4.96
-0.17 (-3.31%)
(As of 09/29/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.82
$5.04
50-Day Range
$4.96
$6.60
52-Week Range
$4.79
$12.22
Volume
241,147 shs
Average Volume
499,656 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.90
CURLF stock logo

About Curaleaf (OTCMKTS:CURLF) Stock

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of June 16, 2022, it operated 134 dispensaries and 26 cultivation sites in 22 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

CURLF Stock News Headlines

Why Curaleaf Stock Got Mashed on Monday
Segment focus
Why Curaleaf Stock Dived by 4% Today
Curaleaf Annual Meeting of Shareholders Reminder
See More Headlines
Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

CURLF Company Calendar

Last Earnings
3/03/2022
Today
9/29/2022
Next Earnings (Estimated)
11/07/2022

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CURLF
Fax
N/A
Employees
5,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$14.90
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+200.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Boris Alexis Jordan (Age 56)
    Exec. Chairman
    Comp: $1.75M
  • Mr. Joseph F. Lusardi (Age 47)
    Exec. Vice-Chairman
    Comp: $1.1M
  • Mr. Joseph Daniel Bayern (Age 59)
    Exec. Officer & Exec. of New Markets
    Comp: $1.35M
  • Mr. Matthew S. Darin
    Chief Exec. Officer
  • Mr. Edward Kremer (Age 50)
    Chief Financial Officer
  • Mr. Joe Holland
    Exec. VP of Operations
  • Mr. Camilo Russi Lyon
    Chief Investment Officer
  • Mr. Jakob Feinstein
    Mang. of Investor Relations
  • Mr. Peter Clateman J.D. (Age 54)
    Chief Legal Officer
  • Mr. James S. Shorris (Age 60)
    Chief Compliance Officer













CURLF Stock - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CURLF shares.
View CURLF analyst ratings
or view top-rated stocks.

What is Curaleaf's stock price forecast for 2022?

9 analysts have issued 12-month target prices for Curaleaf's shares. Their CURLF share price forecasts range from $10.00 to $24.00. On average, they expect the company's share price to reach $14.90 in the next twelve months. This suggests a possible upside of 200.4% from the stock's current price.
View analysts price targets for CURLF
or view top-rated stocks among Wall Street analysts.

How have CURLF shares performed in 2022?

Curaleaf's stock was trading at $9.00 at the start of the year. Since then, CURLF shares have decreased by 44.9% and is now trading at $4.96.
View the best growth stocks for 2022 here
.

Are investors shorting Curaleaf?

Curaleaf saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 940,700 shares, an increase of 71.9% from the August 15th total of 547,200 shares. Based on an average trading volume of 719,500 shares, the days-to-cover ratio is currently 1.3 days.
View Curaleaf's Short Interest
.

When is Curaleaf's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our CURLF earnings forecast
.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) announced its earnings results on Thursday, March, 3rd. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.02.

What is Curaleaf's stock symbol?

Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."

How do I buy shares of Curaleaf?

Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curaleaf's stock price today?

One share of CURLF stock can currently be purchased for approximately $4.96.

How many employees does Curaleaf have?

The company employs 5,600 workers across the globe.

How can I contact Curaleaf?

Curaleaf's mailing address is 301 Edgewater Place, Wakefield, MA 01880. The official website for the company is www.curaleaf.com. The company can be reached via phone at (781) 451-0150.

This page (OTCMKTS:CURLF) was last updated on 9/30/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.